Drawing for Serial No. 79224918

USPTO serial 79224918

Serial No. 79224918

Reviewed by CopyMark Law Group

Reg. 5572714Status 709
Filing date
Status date
Registration date
Oct 2, 2018
Examiner
JAGANNATHAN, SIDDHARTH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79224918?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey D. Larson

Jeffrey D. Larson Holland and Hart LLPP.O. Box 8749Denver, CO 80201UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for medical use, medicines, pharmaceutical preparations for human use, diagnostic products and products for medical diagnosis, chemical preparations for medical use all for the treatment of neurological diseases, auto-immunes diseases, cancers, cardiovasculars diseases, metabolic syndroms; food supplements and nutritional supplements; dietetic food supplements for medical use; dietetic food for medical and pharmaceutical use; homeopathic and plant therapy compositions, namely, homeopathic plant-based supplements; sanitary preparations for medical use; pharmaceutical products for skin and hair care and hygiene namely, medicated hair and skin care preparations; medical preparations for slimming; therapeutic medicated preparations for the bath; bath salts for medical use; medicated bath preparations; dietetic beverages for medical use; appetite suppressants for medical use; royal jelly for pharmaceutical use; oils for medical use, namely, medicinal oils; chemical reagents for medical use, namely, biomarkersSECTION 71 - CANCELLED—
044Medical services; pharmaceutical adviceSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 30, 2026INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 14, 2026INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 14, 2026INPCINVALIDATION PROCESSED—
Dec 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Apr 18, 2025C71TCANCELLED SECTION 71—
Oct 2, 2023REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 28, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 2, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 15, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jan 15, 2019FIMPFINAL DISPOSITION PROCESSED—
Jan 2, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 2, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 21, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 17, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 17, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 4, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jul 4, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jun 27, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 8, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 8, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 8, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2018RFNTREFUSAL PROCESSED BY IB—
Feb 27, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 27, 2018RFRRREFUSAL PROCESSED BY MPU—
Feb 20, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 19, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 13, 2018DOCKASSIGNED TO EXAMINER—
Jan 23, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 17, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 11, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance